Latest Interviews
Showing 646–660 of 809 transcripts.
Clear all filters- a16z26 min
A Skeptic's View of Crypto (from the Point of View of Monetary Economics)
A prominent critic argues that cryptocurrency represents a regression in monetary evolution by mimicking the high resource costs of metallic money rather than advancing toward efficient digital systems. The speaker contends that Bitcoin functions primarily as a speculative asset driven by distrust in government institutions, lacking the intrinsic utility or social trust mechanisms required to stabilize modern economies. Ultimately, the analysis suggests that severe monetary collapses are rooted in broader political failures and that state authorities retain the capacity to regulate or suppress networks that threaten their sovereignty.
- a16z36 min
3 Common Myths People Have About Crypto
Katie Haun, Roya Mahoob, Paul Krugman
Former federal prosecutor, now a cryptocurrency advocate, dismantles prevailing myths regarding digital currency by demonstrating how blockchain forensics effectively traces illicit activity while revealing that crypto serves vital functions like hyperinflation protection and financial inclusion for the unbanked. The speaker distinguishes between Bitcoin as a store of value and blockchain as a trustless infrastructure capable of replacing centralized intermediaries in global finance, drawing parallels between current technological limitations and the early internet era. This presentation, hosted by Nobel laureate Paul Krugman, concludes with an intellectual debate over the sector's future stability despite projections that ten percent of global GDP will eventually rest on blockchain applications.
- a16z23 min
Distribution, Channel & Partnerships
Andreessen Horwitz General Partner Alex Rampell outlines a strategic framework for channel partnerships that prioritizes bi-directional value and market defensibility, illustrated by TrialPay's acquisition-driven growth. By targeting partners with sputtered growth like Download.com rather than dominant players such as PayPal, TrialPay secured an exclusive arrangement that generated $5 million in revenue while creating a competitive moat that forced rival media companies to exit the market. The narrative demonstrates that successful channel strategies rely on precise relevance filtering and behind-the-scenes economics to align incentives, ultimately enabling companies to serve the long tail of small merchants where traditional direct sales fail.
- a16z27 min
Product Marketing for New Products
This presentation establishes a product marketing framework that aligns marketing, sales, and engineering to solve key adoption barriers like technical confusion, budget constraints, and unrecognized customer needs. The speaker details a narrative-driven deck structure and pricing strategies that guide buyers through new market categories while leveraging executive briefings and face-to-face iterations for validation. By centralizing sales collateral ownership and employing competitive battle cards, the framework ensures consistent messaging and optimized deal structures across all customer segments.
- Milken Institute29 min
A Conversation with Francis Collins, Director, National Institutes of Health
Francis Collins, Meg Tirrell, Richard Ditizio, Synim Rivers
The event highlights a critical gender and racial leadership gap in healthcare, where women comprise half the workforce but hold only 3% of CEO roles, prompting organizations like Horizon Pharma to sign diversity pledges and adopt business resource groups to drive financial and clinical innovation. Parallel to these corporate initiatives, the NIH's "All of Us" research program and the Brain Initiative are launching large-scale, data-driven efforts to individualize medicine and accelerate cures for Alzheimer's and other neurological conditions by mapping billions of neurons and enrolling a diverse cohort of one million participants. These combined strategies aim to transform healthcare from a one-size-fits-all model into a precision-based system supported by robust funding, emerging gene therapies for sickle cell disease, and immunotherapy breakthroughs for metastatic cancers.
- Milken Institute36 min
Addressing Social Determinants to Improve Health Outcomes
Anand Parekh, Karen DeSalvo, Esther Dyson, Sergio Matos, Alan Moses, Lydia, Mark Hyman, Helen
Former health officials and community leaders convened to argue that social determinants like housing and food security drive 80% of health outcomes, citing Humana and CMS data where interventions yielded significant cost savings and improved well-being. Despite evidence supporting community health workers and local partnerships, the panel identified rigid funding structures, actuarial caution, and an overreliance on randomized trials as primary barriers to mainstreaming these models. Strategic recommendations include integrating social factors into Medicaid reimbursement, shifting from short-term grants to sustainable community ownership, and redefining health as a systemic design issue rather than a purely clinical one.
- Milken Institute27 min
CDC Director Robert Redfield: 'Opioid Epidemic is the public health crisis of our time'
This event details a strategic review of an organization facing significant funding uncertainties and access barriers while pivoting toward social justice, independent scientific research, and multi-year capital market transitions. Key figures addressed the contradiction between current resource limitations and plans to expand operations through federal partnerships over a projected three-year timeline to better manage global crises. Despite ambiguous historical anchors and disjointed narrative segments, the discussion concluded with a commitment to advancing systemic reforms and developing spiritual leadership capabilities among students.
- Y Combinator40 min
How to Apply and Succeed at Y Combinator by Dalton Caldwell
The event details how applying to Y Combinator serves as a critical strategic exercise that forces founders to clarify business fundamentals while systematically dismantling common misconceptions regarding timing, industry fit, and team requirements. It outlines a rigorous application protocol where completeness, concise storytelling, and demonstrable execution capability outweigh prior experience or networks, emphasizing that the process itself builds skills transferable to scaling the venture. Furthermore, the discussion highlights that the partnership interview functions as a collaborative verification of these metrics rather than a trivia quiz, providing specific feedback loops that encourage strategic re-application based on tangible progress.
- Goldman Sachs38 min
James Murdoch: Transforming the Future of Entertainment
James Murdoch outlines his transformational career spanning the restructuring of Star TV in Asia, the digital pivot of BSkyB in Europe, and the strategic simplification of 21st Century Fox to prepare for the Disney acquisition. He argues that vertical integration and content volume are now essential for competing against digital disruptors like Netflix while addressing critical industry challenges regarding advertising models and social media manipulation. Drawing on lessons from his Tesla board tenure, Murdoch projects a future defined by ubiquitous high-speed connectivity and immersive virtual realities that will fundamentally redefine media consumption.
- The Economist25 min
Tony Blair on the future of liberalism
Marking the 175th anniversary of *The Economist* and the 21st anniversary of New Labour, former Prime Minister Tony Blair reflects on the 1998, 2003, and 2004 policy decisions that contributed to modern societal fractures while outlining a renewal strategy for liberalism. Blair proposes addressing root causes of polarization through strict immigration controls without prejudice, a proactive technological policy agenda, and a return to positive-sum economic growth to counter the rise of populism. Urging the restoration of a rational political center, he suggests resolving the Brexit impasse via a second referendum and warns that without a centrist platform, the UK risks perpetual political paralysis between the extremes.
- Goldman Sachs45 min
Tim Brown and Joey Zwillinger: Making Footwear Sustainable, Comfortable and Cool
Tim Brown, Joey Zwillinger, Kathy Elsesser
Founded in 2016 by Tim Brown and Joey Zwillinger, Allbirds operates as a certified B Corp that disrupts the footwear industry by prioritizing sustainable material science through its direct-to-consumer model. The company leverages a co-CEO leadership structure and a rigorous "one product at a time" philosophy to rapidly iterate designs based on direct customer feedback, successfully launching innovations like the Wool Runner and eucalyptus fiber while maintaining a flat price point. With plans to expand internationally and open physical retail locations for tactile testing, Allbirds aims to normalize sustainable manufacturing standards across the fashion sector.
- Goldman Sachs34 min
Interns Meet Our Next Chairman and CEO, David Solomon, During an 'Explore GS' Session
Following a direct succession from Lloyd Blankfein, David Solomon assumes the CEO role at Goldman Sachs at age 56, becoming the firm's first non-partner leader since its 1999 public offering. Solomon is steering the 150-year legacy from a private partnership into a public corporation by targeting a 50% gap in corporate product offerings and integrating advanced data analytics to expand commercial banking services. Simultaneously, he prioritizes cultural evolution by framing diversity as a business imperative and advising talent to pursue long-term networking and patient career development over short-term acceleration.
- Goldman Sachs23 min
Dr. Siddhartha Mukherjee: Genetically Mapping the Future of Cancer
Siddhartha Mukherjee, Richard Manley
Dr. Siddharth Mukherjee outlines a paradigm shift in oncology where cancer is treated as a portfolio of distinct conditions managed through prevention, targeted early detection, and immunotherapy rather than a single curable entity. Advances in genetic engineering have moved the field from simply sequencing DNA to actively editing sequences, enabling cures for single-gene disorders and transforming historically lethal cancers like metastatic HER2-positive breast cancer into manageable chronic conditions. This revolution, driven by the ability to replace nucleotides and alter cellular environments, marks a historical transition comparable to the dawn of the computer age in its capacity to redefine human health.
- a16z27 min
An Intro to Crypto: Building Companies, from People to Code
Kim Milosevich, Tina Bhatnagar, Preethi Kasireddy, Lily Liu, Preeti
Industry leaders Preeti and Tina analyze the maturation of the crypto sector by challenging absolute decentralization myths while advocating for a messaging shift from censorship resistance to consumer empowerment. The discussion highlights structural transformations in company formation, noting that token-based funding and community-driven governance enable entities like Binance to scale rapidly with minimal overhead. Furthermore, experts emphasize that navigating existential regulatory challenges and prioritizing user education are now critical prerequisites for integrating blockchain technology into mainstream institutional infrastructure.
- Y Combinator27 min
Jessica Livingston Shares 9 Things She Learned From Founding YC
Founded in 2005 by Paul Graham and Jessica Livingston, Y Combinator revolutionized early-stage funding by implementing a batch model that supported over 1,800 startups through small equity stakes and an intentional "asshole-free" culture. Livingston, acting as the organization's social radar, prioritized founder dynamics and well-being over technical prowess, a strategy that facilitated unique successes like Reddit and Twitch while establishing a global network free from traditional investor pressure. Their complementary partnership, defined by Graham's technical vision and Livingston's focus on logistics and culture, created a resilient ecosystem that advises founders to pursue non-traditional paths rather than conforming to stereotypical success metrics.